FDA Inspection 983014 — Aidarex Pharmaceuticals LLC

Aidarex Pharmaceuticals LLC — FEI 3006286571

The FDA completed an inspection of Aidarex Pharmaceuticals LLC on June 6, 2016 in Corona, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 6, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Corona, CA (United States)